Similar articles

• Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.

  Gothelf D, Falk B, Singer P, Kairi M, Phillip M, Zigel L, Poraz I, Frishman S, Constantini N, Zalsman G, Weizman A, Apter A. Gothelf D, et al. Am J Psychiatry. 2002 Jun;159(6):1055-7. doi: 10.1176/appi.ajp.159.6.1055. Am J Psychiatry. 2002. PMID: 12042200 Clinical Trial.
• Is olanzapine a brain-sparing medication?

  Joober R, Schmitz N, Malla A, Sengupta S, Karma S. Joober R, et al. Arch Gen Psychiatry. 2006 Nov;63(11):1292. doi: 10.1001/archpsyc.63.11.1292. Arch Gen Psychiatry. 2006. PMID: 17088510 No abstract available.
• Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.

  Chen CH, Huang MC, Lu ML. Chen CH, et al. J Clin Psychopharmacol. 2007 Oct;27(5):516-7. doi: 10.1097/JCP.0b013e31814fb9a3. J Clin Psychopharmacol. 2007. PMID: 17873689 No abstract available.
• Mechanisms of antipsychotic-induced weight gain.

  McIntyre RS, Mancini DA, Basile VS. McIntyre RS, et al. J Clin Psychiatry. 2001;62 Suppl 23:23-9. J Clin Psychiatry. 2001. PMID: 11603882 Review.
• Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.

  Karagianis J, Hoffmann VP, Arranz B, Treuer T, Maguire GA, de Haan L, Chawla B. Karagianis J, et al. Hum Psychopharmacol. 2008 Jun;23(4):275-81. doi: 10.1002/hup.933. Hum Psychopharmacol. 2008. PMID: 18338426 Review.